
Abbott (ABT) is poised to report its Q2 2025 earnings on July 17, with consensus estimates forecasting $1.25 EPS, a 9.7% year-over-year increase, on revenues of $11.07 billion, up 6.7%. Despite a minor 0.44% downward revision to the consensus EPS estimate over the past 30 days, Zacks' analysis indicates a high probability of an earnings beat, driven by a positive Earnings ESP of +0.96% and a Zacks Rank #2. This combination, alongside a history of beating estimates in three of the last four quarters, positions ABT as a strong candidate for an upside surprise, though broader market dynamics will also influence post-release stock performance.
Abbott (ABT) is approaching its Q2 2025 earnings release on July 17 with expectations for significant year-over-year growth, as consensus estimates project a 9.7% increase in EPS to $1.25 and a 6.7% rise in revenue to $11.07 billion. While the consensus EPS estimate has been revised downward by a marginal 0.44% over the last 30 days, more recent indicators suggest a strong likelihood of an earnings beat. The company's Zacks Earnings ESP (Expected Surprise Prediction) is a positive 0.96%, indicating that the most recent analyst estimates are more bullish than the consensus. This positive ESP, combined with a Zacks Rank of #2 (Buy), creates a statistical profile that has historically resulted in a positive earnings surprise nearly 70% of the time. This quantitative outlook is further supported by Abbott's recent performance, having surpassed consensus EPS estimates in three of the last four quarters, including a 1.87% beat in the prior quarter. The combination of these factors presents a compelling case for an upside surprise, though the stock's ultimate trajectory will also heavily depend on management's forward-looking guidance provided during the earnings call.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.60
Ticker Sentiment